<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AID</journal-id><journal-title-group><journal-title>Advances in Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-2648</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aid.2022.122020</article-id><article-id pub-id-type="publisher-id">AID-117522</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Epidemiological, Clinical and Outcome Aspects of Care-Related Tetanus in Dakar, Senegal
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Viviane</surname><given-names>Marie Pierre Cisse</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ndèye</surname><given-names>Fatou Ngom Gueye</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Louise</surname><given-names>Fortes</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Imelda</surname><given-names>Mickelina Thoo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aminata</surname><given-names>Massaly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Khardiata</surname><given-names>Diallo Mbaye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Daye</surname><given-names>Ka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ndèye</surname><given-names>Aissatou Lakhe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Assane</surname><given-names>Diouf</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ndèye</surname><given-names>Maguette Fall</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Daouda</surname><given-names>Thioub</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aboubakry</surname><given-names>Sidikh Badiane</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Latyr</surname><given-names>Junior Diouf</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alassane</surname><given-names>Sarr</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sylvie</surname><given-names>Audrey Diop</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cheikh</surname><given-names>Tidiane Ndour</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Masserigne</surname><given-names>Soumaré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moussa</surname><given-names>Seydi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Infectious and Tropical Diseases Department, Fann Teaching University Hospital, Dakar, Senegal</addr-line></aff><aff id="aff2"><addr-line>Department of Community Health, Alioune Diop University, Bambey, Senegal</addr-line></aff><aff id="aff3"><addr-line>Department of Health, Thies University, Thies, Senegal</addr-line></aff><pub-date pub-type="epub"><day>29</day><month>04</month><year>2022</year></pub-date><volume>12</volume><issue>02</issue><fpage>230</fpage><lpage>240</lpage><history><date date-type="received"><day>10,</day>	<month>April</month>	<year>2022</year></date><date date-type="rev-recd"><day>28,</day>	<month>May</month>	<year>2022</year>	</date><date date-type="accepted"><day>31,</day>	<month>May</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution-NonCommercial International License (CC BY-NC).http://creativecommons.org/licenses/by-nc/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Tetanus portals of entry are numerous. Amongst these, the carerelated portals of entry are rarely reported. The aim of the study was to describe the epidemiological, clinical and outcome aspects and identify the factors associated with death from care-related tetanus. 
  Patients and Methods: This is a retrospective study of descriptive and analytical purposes. Data were collected from the medical records of patients admitted to the Infectious and Tropical Diseases Department of the National University Hospital Center (CHNU) of Fann in Dakar for care-related tetanus during the period ranging from 1 January 2009 to 31 December 2016. Care-related tetanus was defined as any case of tetanus occurring after a surgical procedure, including circumcisions performed even outside a health facility. 
  Results: In eight years, 50 cases of care-related tetanus were recorded. Care-related tetanus accounted for 6.7% of hospitalized tetanus cases. The mean age of patients was 21 &#177; 22 years, with a male predominance (sex ratio: 6.14). The procedure had been performed in most cases, either in a health facility in 22 patients (44%) or at home in 16 patients (32%), and occurred after circumcision. In 62% of cases the portal of entry was urological, followed by orthopedic surgery (14%) and visceral surgery (10%). The procedures performed were dominated by circumcision (31 cases), limb amputation (3 cases) and inguinal hernia repair (2 cases). Tetanus was immediately generalized on admission in all patients. Eighty-four percent (84%) of patients were admitted with Mollaret stage II. Cardiovascular (11 cases), infectious (10 cases) and respiratory (9 cases) complications were the most frequent. The hospital case fatality rate was 24%. Factors associated with death were female gender (p = 0.03), age between 15 - 60 years (p = 0.02), incubation time &lt; 7 days (p = 0.003), presence of complication (p = 0.001). 
  Conclusion: Care-related tetanus remains a concern in poor income countries, particularly in Senegal. The drop of these cases will require better immunization coverage of the population. It is also appropriate to raise the awareness of health care providers and surgeons and to promote capacity building for better prevention of cases through sero-immunization of patients at risk before the procedure and rigorous asepsis.
 
</p></abstract><kwd-group><kwd>Tetanus</kwd><kwd> Care</kwd><kwd> Surgery</kwd><kwd> Dakar</kwd><kwd> Senegal</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>In poor income countries, particularly in Africa, tetanus remains a public health concern due to its frequency and severity despite the existence of effective immunization [<xref ref-type="bibr" rid="scirp.117522-ref1">1</xref>]. Tetanus remains a public health problem in developing countries with an annual incidence rate of 10 to 50 per 100,000 population [<xref ref-type="bibr" rid="scirp.117522-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref3">3</xref>]. Senegal is one of the African countries where tetanus in children and adults remains a concern, despite the efforts made through the expanded programme on immunization [<xref ref-type="bibr" rid="scirp.117522-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref6">6</xref>]. Despite the relevant experience acquired in the management of tetanus in hospitals, the lethality remains high (20% to 30%) [<xref ref-type="bibr" rid="scirp.117522-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref7">7</xref>], due to the impact of several unknown factors that influence the prognosis of the disease [<xref ref-type="bibr" rid="scirp.117522-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref9">9</xref>]. Tetanus portals of entry are numerous. Amongst these, the care-related portals of entry are rarely reported. Tetanus can result from any surgical procedure and has a very poor prognosis because of its severity and high mortality rate, which can reach 50% [<xref ref-type="bibr" rid="scirp.117522-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref11">11</xref>]. Previous studies carried out in Senegal and elsewhere in Africa [<xref ref-type="bibr" rid="scirp.117522-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref14">14</xref>] show that tetanus following surgery is a reality. It represents a medical scandal and poses a medico-legal concern. It features a higher lethality compared to certain portals of entry. Our study aimed to describe the epidemiological, clinical, and outcome aspects of care-related tetanus and to identify the factors associated with death in these patients.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This is a retrospective study of descriptive and analytical purposes carried out on the medical records of patients hospitalized for tetanus over an 8-year period range from 1 January 2009 to 31 December 2016 in the infectious and tropical diseases department of National University Hospital Center (CHNU) in Dakar, Senegal. It is the referral service for the management of patients with tetanus in Senegal. We included patients hospitalized for care-related tetanus. We defined care-related tetanus as any case of tetanus occurring after a surgical procedure, including circumcisions performed even outside a health facility. We did not include cases of neonatal tetanus in this study. The diagnosis of tetanus relied on epidemiological (presence of portal of entry, absence of immunization or notion of incomplete immunizaton), clinical (presence of trismus associated or not with dysphagia, contractures and/or paroxysms). Tetanus diagnosis was purely based on clinical features. Data were collected on an individual survey form from the patients medical records and hospital registers. They involved socio-demographic aspects (sex, age, geographical origin, tetanus vaccine status, type of surgery, type of procedure performed); clinical aspects (incubation period, invasion period, clinical pattern); prognostic aspects (Mollaret stage classification and Dakar score) and outcome aspects (complications, recovery, death, transfer). Data entry and processing were carried out using Epi-info software version 7.1.2. The categorical variables were described by the number and frequency in each class. Graphs were performed in excel. For the univariate analysis, the Pearson Chi-square test or the Fischer test was used to search for factors associated with the occurrence of patient death. A p-value of &lt;0.05 was used as a significance threshold.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Epidemiological Aspects</title><p>During the study period from 2009 to 2016, we studied 741 cases of tetanus from all admissions (8306 patients) and 50 cases of tetanus related to care, accounting for a hospital prevalence of 0.6% (50/8306) and a proportional morbidity of 6.7% (50/741). Annual variations over the years were noted (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The average number of cases was 6.3 per year. There was a clear male predominance with a sex ratio of 6.14. The mean age of the patients was 21 &#177; 22 years with extremes of 6 months and 74 years. Among the patients, 62% were aged 1 - 15 years (<xref ref-type="table" rid="table1">Table 1</xref>). The majority of patients were from Dakar suburb (62%). Twenty eight patients, standing for 56% of the cases, didn’t undergo tetanus sero-immunization neither before nor after the procedure. Information on the place of intervention</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Characteristics of patients admitted for care related tetanus at the Infectious and tropical diseases department of Fann University Hospital center in Dakar-Senegal, from 2009 to 2016</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Number of cases</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Age group (year)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >1 - 15</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >62</td></tr><tr><td align="center" valign="middle" >16 - 60</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >24</td></tr><tr><td align="center" valign="middle" >&gt;60</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >12</td></tr><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >86</td></tr><tr><td align="center" valign="middle" >female</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Tetanus sero vaccination</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >realized</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Not realized</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >56</td></tr><tr><td align="center" valign="middle" >Not specified</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >Surgery type</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Urology</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >62</td></tr><tr><td align="center" valign="middle" >Orthopedics</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Digestive</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Others (gynecology, ORL,)</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Incubation period</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;7 days</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >≥7 days</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >80</td></tr><tr><td align="center" valign="middle" >Invasion period</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;48 hours ≥48 hours</td><td align="center" valign="middle" >26 24</td><td align="center" valign="middle" >52 48</td></tr><tr><td align="center" valign="middle" >Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Trismus</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Dysphagia</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >74</td></tr><tr><td align="center" valign="middle" >Tonic paroxysm</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >60</td></tr><tr><td align="center" valign="middle" >Tonic clonic paroxysm</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >Mollaret stage</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Stage I</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >Stage II</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >84</td></tr><tr><td align="center" valign="middle" >Stage IIIa</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Stage IIIb</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >Outcome of hospitalization</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Recovery</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >72</td></tr><tr><td align="center" valign="middle" >Transfer</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Death</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >24</td></tr></tbody></table></table-wrap><p>was available for 38 patients (76%). The procedure was performed in most cases, either in a health facility in 22 patients (44%) or at home in 16 patients (32%) and represented cases of circumcision. In two-third of the cases 31/50 patients (62%) the infection portal of entry was urological, followed by orthopedic surgery (7/50 cases) and visceral surgery (5/50 cases) with 14% and 10% of cases respectively. The procedure performed was dominated by circumcision (31 cases), limb amputation (3 cases) and inguinal hernia repair (2 cases). The different procedures performed are detailed in <xref ref-type="table" rid="table2">Table 2</xref>.</p></sec><sec id="s3_2"><title>3.2. Clinical, Prognostic and Outcome Aspects</title><p>In 80% of cases the incubation period was equal to or longer than 7 days and the invasion period was less than 48 hours in 52% of patients. Tetanus was immediately generalized in all patients. Trismus (100%) and dysphagia (74%) were the main clinical signs. More than two-third of the patients (68%) underwent paroxysms. Mollaret stage II was found in 84% of patients on admission (<xref ref-type="table" rid="table1">Table 1</xref>). A score between 2 - 3 of the Dakar international classification was found in 78% of the patients and in 4 patients this score was higher than 4, including two circumcisions, a cure for vesicular lithiasis and nasal vegetation.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Surgery type and act performed of patients admitted for care related tetanus at the infectious and tropical diseases department of Fann University Hospital center in Dakar-Senegal, from 2009 to 2016</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Type of surgery</th><th align="center" valign="middle" >Procedure performed</th><th align="center" valign="middle" >Number of cases</th></tr></thead><tr><td align="center" valign="middle" >Urology</td><td align="center" valign="middle" >circumcisions</td><td align="center" valign="middle" >31</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >Orthopedic</td><td align="center" valign="middle" >limb Amputation</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >osteosynthesis</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >installation of a screwed plate</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >leg abscess drainage</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >fracture surgery</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Digestive</td><td align="center" valign="middle" >inguinal hernia repair</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >appendectomy</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Grelic resection and ileostomy</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Cure fo vesicular lithiasis</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >ORL and Stomatology</td><td align="center" valign="middle" >nasal vegetations cure</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >naso sinus Polyp rfemoval</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >laser procedure</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >dental extraction</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Gynecology</td><td align="center" valign="middle" >hysterectomy</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >dermoid cyst surgery</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Oncology</td><td align="center" valign="middle" >breast biopsy</td><td align="center" valign="middle" >1</td></tr></tbody></table></table-wrap><p>During hospitalisation, 22 patients (44%) had undergone at least one complication. Cardiovascular (11 cases), infectious (10 cases) and respiratory (9 cases) complications were the most common. Infectious complications were dominated by pneumonia (12%), sepsis (12%) and urinary tract infections 4%. Among the cases of bacterial pneumopathy, Pseudomonas aeruginosa was found in one patient. For the 6 cases of septicaemia that occurred, the blood culture isolated Staphylococcus saprophyticus in one patient and Staphylococcus aureus in two cases. Regarding urinary tract infections, cytobacteriological examination of the urine isolated Pseudomonas aeruginosa and Klebsiella pneumoniae. Cardiovascular complications were mainly represented by heart attack (10%) and rhythm disorders (8%). Respiratory distress (8%), laryngospasm (8%) and apnoea (8%) were the main respiratory complications.</p></sec><sec id="s3_3"><title>3.3. Lethality and Factors Associated to Death</title><p>Among the 50 patients, the outcome was fatal for 12 (24%). Death mainly occured after septic shock (5 cases) and heart attack (4). Poor prognostic factors included female gender (p = 0.03), age between 15 and 60 years (p = 0.02), incubation &lt; 7 days (p = 0.003) and the presence of a complication (p = 0.001) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Factors associated with death of patients admitted for care related tetanus at the Infectious and tropical diseases department of Fann University Hospital center in Dakar-Senegal, from 2009 to 2016</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  colspan="2"  >Death</th><th align="center" valign="middle"  rowspan="2"  >p value</th></tr></thead><tr><td align="center" valign="middle" >Yes N (%)</td><td align="center" valign="middle" >No N (%)</td></tr><tr><td align="center" valign="middle" >Age group (years)</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;15</td><td align="center" valign="middle" >4 (12.5)</td><td align="center" valign="middle" >28 (87.5)</td><td align="center" valign="middle"  rowspan="3"  >0.02</td></tr><tr><td align="center" valign="middle" >15 - 60</td><td align="center" valign="middle" >3 (60.0)</td><td align="center" valign="middle" >2 (40.0)</td></tr><tr><td align="center" valign="middle" >&gt;60</td><td align="center" valign="middle" >5 (32.5)</td><td align="center" valign="middle" >8 (61.5)</td></tr><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >4 (57.1)</td><td align="center" valign="middle" >3 (42.9)</td><td align="center" valign="middle"  rowspan="2"  >0.03</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >8 (18.6)</td><td align="center" valign="middle" >35 (81.4)</td></tr><tr><td align="center" valign="middle" >Type of surgery</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Urology</td><td align="center" valign="middle" >4 (12.5)</td><td align="center" valign="middle" >28 (87.5)</td><td align="center" valign="middle"  rowspan="3"  >0.08</td></tr><tr><td align="center" valign="middle" >Visc&#233;ral</td><td align="center" valign="middle" >3 (60.0)</td><td align="center" valign="middle" >2 (40.0)</td></tr><tr><td align="center" valign="middle" >Others *</td><td align="center" valign="middle" >5 (32.5)</td><td align="center" valign="middle" >8 (61.5)</td></tr><tr><td align="center" valign="middle" >Incubation period</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;7 days</td><td align="center" valign="middle" >6 (60)</td><td align="center" valign="middle" >4 (40)</td><td align="center" valign="middle"  rowspan="2"  >0.03</td></tr><tr><td align="center" valign="middle" >≥7 days</td><td align="center" valign="middle" >6 (15)</td><td align="center" valign="middle" >34 (85)</td></tr><tr><td align="center" valign="middle" >Invasion period</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;48 hours</td><td align="center" valign="middle" >9 (34.6)</td><td align="center" valign="middle" >17 (65.4)</td><td align="center" valign="middle"  rowspan="2"  >0.07</td></tr><tr><td align="center" valign="middle" >≥48 hours</td><td align="center" valign="middle" >3 (12.5)</td><td align="center" valign="middle" >21 (87.5)</td></tr><tr><td align="center" valign="middle" >paroxysm</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Present</td><td align="center" valign="middle" >7 (21.9)</td><td align="center" valign="middle" >25 (78.3)</td><td align="center" valign="middle"  rowspan="2"  >0.63</td></tr><tr><td align="center" valign="middle" >Absent</td><td align="center" valign="middle" >5 (16.7)</td><td align="center" valign="middle" >13 (72.2)</td></tr><tr><td align="center" valign="middle" >Mollaret stage</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Stage I</td><td align="center" valign="middle" >3 (75.0)</td><td align="center" valign="middle" >1 (25.0)</td><td align="center" valign="middle"  rowspan="4"  >0.47</td></tr><tr><td align="center" valign="middle" >Stage II</td><td align="center" valign="middle" >7 (16.7)</td><td align="center" valign="middle" >35 (83.3)</td></tr><tr><td align="center" valign="middle" >Stage IIIa</td><td align="center" valign="middle" >0 (0.0)</td><td align="center" valign="middle" >1 (100)</td></tr><tr><td align="center" valign="middle" >Stage IIIb</td><td align="center" valign="middle" >2 (66.7)</td><td align="center" valign="middle" >1 (33.3)</td></tr><tr><td align="center" valign="middle" >Existence or not of tares</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >3 (37.5)</td><td align="center" valign="middle" >5 (62.5)</td><td align="center" valign="middle"  rowspan="3"  >0.09</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >3 (11.5)</td><td align="center" valign="middle" >23 (88.5)</td></tr><tr><td align="center" valign="middle" >Not specified</td><td align="center" valign="middle" >6 (37.5)</td><td align="center" valign="middle" >10 (62.5)</td></tr><tr><td align="center" valign="middle" >Complications</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >10 (45.5)</td><td align="center" valign="middle" >12 (54.5)</td><td align="center" valign="middle"  rowspan="2"  >0.001</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >2 (7.1)</td><td align="center" valign="middle" >26 (92.9)</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussion</title><p>Tetanus remains a concern in Senegal. Care-related portal of entry is scarcely reported but constitutes a reality in our poor income countries [<xref ref-type="bibr" rid="scirp.117522-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref14">14</xref>]. The proportional morbidity of 6.7% found in our study is higher than that of a previous senegalese series which found a rate of 1.75% [<xref ref-type="bibr" rid="scirp.117522-ref11">11</xref>] and lower than that of an Ivorian series which was 11% [<xref ref-type="bibr" rid="scirp.117522-ref14">14</xref>]. This difference in prevalence is due to methodological approaches such as the non-inclusion of circumcision cases in the Senegalese study and the inclusion of surgical wounds in the Ivorian study. Fortes in 2015 in the same department [<xref ref-type="bibr" rid="scirp.117522-ref15">15</xref>] and Ngaha [<xref ref-type="bibr" rid="scirp.117522-ref16">16</xref>] in Burkina Faso in 2014 found in their various studies that the post-surgical portal of entry ranked second after the integumentary portal of entry with respectively 7% and 11.1%. These results prove the fact of care-related tetanus in our hospitals and should therefore be of concern to all health care providers. The male predominance noted in our study with a sex ratio of 6.14 is reported in most African series, whatever the age group and tetanus clinical pattern [<xref ref-type="bibr" rid="scirp.117522-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref14">14</xref>]. Care-related tetanus in our series affected more children between 1 and 15 years of age. This is explained by the high frequency of circumcision in our series (31 cases), which is more often performed in this age group. These results also show that the immunization schedule, which protects children up to the age of 10, is not respected. Furthermore, booster shots are not usually given because they are under the charge of parents.</p><p>Serotherapy and tetanus immunization were not performed neither before nor after the procedure in 56% of cases. However, in our countries where tetanus remains a health concern, practitioners should seize every opportunity to update both serotherapy and tetanus immunization if necessary in order to improve immunization coverage. Despite the tetanus serotherapy carried out in an Ivorian study, 59% of patients had developed tetanus following surgery [<xref ref-type="bibr" rid="scirp.117522-ref14">14</xref>], hence the interest in combining tetanus vaccination in high-risk patients [<xref ref-type="bibr" rid="scirp.117522-ref17">17</xref>].</p><p>The urological portal of entry was the most common route with 62% of cases represented solely by circumcisions in our series (31/50 cases). Circumcisions constitute an entry point, particularly those performed outside a health facility. In this case, the occurrence of tetanus would be due to circumcision being performed by unqualified personnel or by a caregiver practising at home under precarious aseptic conditions. After the circumcisions, the other procedures were multiple, dominated by limb amputations (3 cases), the installation of osteosynthesis material or a screwed plate (2 cases) and inguinal hernia repair (2 cases). These data are similar to those of Dia [<xref ref-type="bibr" rid="scirp.117522-ref11">11</xref>] who found a predominance of urological (42%) and orthopedic (29%) surgery with inguinal hernia repair and amputations as the main procedures performed. In contrast to our study, the cases of tetanus after urological surgery were secondary to prostatectomies, internal urostomy and hydrocele cure in this study.</p><p>Elsewhere, Aba [<xref ref-type="bibr" rid="scirp.117522-ref14">14</xref>] in Ivory Coast reported 6 cases of tetanus due to inguinal hernia repairs and cases of breast tumour removal, Fournier’s gangrene, and skin abscesses. In Guinea, [<xref ref-type="bibr" rid="scirp.117522-ref13">13</xref>] in a study of nosocomial tetanus, Traor&#233; noted 16 cases secondary to hernia repair, 7 cases following amputation and 2 cases due to prostatectomy. It is important to note that tetanus can also occur after minor surgical procedures. We have recorded one case of tetanus after breast biopsy. Regarding gynecological portal of entry, our study revealed that tetanus occurred after hysterectomy and dermoid cysts cure, contrary to the work of Manga in Senegal [<xref ref-type="bibr" rid="scirp.117522-ref6">6</xref>] and Doutchi in Niger [<xref ref-type="bibr" rid="scirp.117522-ref18">18</xref>], where the cases recorded were following abortion.</p><p>Clinically, generalized tetanus found in our series is in line with the data of Aba [<xref ref-type="bibr" rid="scirp.117522-ref14">14</xref>] who reported the same course with the presence of a tight trismus, generalized muscle contractures and more or less sub-intensive paroxysms. This demonstrates the severity of tetanus with a care-associated portal of entry as reported by other authors [<xref ref-type="bibr" rid="scirp.117522-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref20">20</xref>].</p><p>Regarding the outcome aspects, the predominance of cardiovascular, infectious and respiratory complications was comparable to that of Attinsounon [<xref ref-type="bibr" rid="scirp.117522-ref21">21</xref>]. Infectious complications were mainly represented by pneumopathy and septicaemia. These results corroborate with those of Fortes in Dakar where pneumopathies represented 63% of infectious complications followed by septicaemia (17%) [<xref ref-type="bibr" rid="scirp.117522-ref15">15</xref>]. In the intensive care unit, pulmonary infections are frequently observed and are most often nosocomial [<xref ref-type="bibr" rid="scirp.117522-ref22">22</xref>]. Moreover, during tetanus, decubitus, salivary stasis, damage to smooth muscles, particularly laryngeal muscles, and contracture of the thoracic muscles are factors that favour inhalation pneumonia.</p><p>Advanced age has been reported by several authors [<xref ref-type="bibr" rid="scirp.117522-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.117522-ref23">23</xref>] as a factor associated with the risk of death as found in our study. The fragility and the presence of an underlying condition explain this high mortality. The presence of complications in our series was correlated with an increase in lethality (p = 0.001). These results are similar to those of Seydi [<xref ref-type="bibr" rid="scirp.117522-ref7">7</xref>] and Manga [<xref ref-type="bibr" rid="scirp.117522-ref24">24</xref>] who found that the presence of complications and the nature of the portal of entry were related to death. These data also confirm the relevance of the elements taken into account in the two classifications of tetanus to assess the prognosis of patients. However, they need to be updated by including some factors that have been identified in many studies as being associated with patient death, namely advanced age and complication occurrence [<xref ref-type="bibr" rid="scirp.117522-ref15">15</xref>]. The small size of our sample undoubtedly explains the fact that we did not find an association between death and the period of invasion, the presence of paroxysms and the surgical approach.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Care-related tetanus is still a concern in poor income countries, particularly in Senegal, with circumcision as the main portal of entry in our study. It is characterized by a high lethality. The reduction of cases will necessarily require better immunization coverage, in particular a strengthening of vaccination campaigns and booster shots for children over five years of age. It is also important to raise awareness among surgeons and to strengthen their capacities for better prevention of cases through vaccination and rigorous asepsis.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Cisse, V.M.P., Gueye, N.F.N., Fortes, L., Thoo, I.M., Massaly, A., Mbaye, K.D., Ka, D., Lakhe, N.A., Diouf, A., Fall, N.M., Thioub, D., Badiane, A.S., Diouf, L.J., Sarr, A., Diop, S.A., Ndour, C.T., Soumar&#233;, M. and Seydi, M. (2022) Epidemiological, Clinical and Outcome Aspects of Care-Related Tetanus in Dakar, Senegal. Advances in Infectious Diseases, 12, 230-240. https://doi.org/10.4236/aid.2022.122020</p></sec></body><back><ref-list><title>References</title><ref id="scirp.117522-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Roue, R. and Rapp, C. (2001) Prévention du tétanos. Rev Prat, 52, 877-880.</mixed-citation></ref><ref id="scirp.117522-ref2"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Santoni</surname><given-names> F. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>Programme élargi de vaccination: 25 ans demain</article-title><source> Med Trop</source><volume> 61</volume>,<fpage> 177</fpage>-<lpage>186</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.117522-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Pilly, E. (2006) Maladies infectieuses. 2e edition, Masson, Paris, 707 p.</mixed-citation></ref><ref id="scirp.117522-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Seydi, M., Soumare, M., Sow, P.S., Diop, B.M., Ndour, C.T., Dia, N.M., et al. (2000) Tétanos: Aspects épidémiologiques à la clinique des maladies infectieuses du CHU de Fann à Dakar. Dakar Médical, 45, 5-7.</mixed-citation></ref><ref id="scirp.117522-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Soumare, M., Ndour, C.T., Ndour, J.D. and Diop, B.M. (2005) Aspects épidémiologiques, cliniques, et pronostiques du tétanos juvénile à Dakar, Sénégal. Bulletin de la Société de pathologie exotique, 98, 371-373.</mixed-citation></ref><ref id="scirp.117522-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Manga, N.M., Ndour, C.T., Fortes, L., Diop, S.A., Dia, N.M., et al. (2009) Le tétanos de la femme en age de procréer à la clinique des maladies infectieuses de Dakar. Bulletin de la Société de pathologie exotique, 102, 221-225.</mixed-citation></ref><ref id="scirp.117522-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Seydi, M., Soumare, M., Gbangba-ngai, E., Mougue Ngadeu, J.F., Diop, B.M., Ndiaye, B. and Sow, P.S. (2005) Aspects actuels du tétanos de l'enfant et de l'adulte à Dakar. Médecine et Maladies Infectieuses, 35, 28-32. https://doi.org/10.1016/j.medmal.2004.11.003</mixed-citation></ref><ref id="scirp.117522-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Minta, K., Traoré, A.M., Soucko, A.K., Dembélé, M., Coulibaly, Y., et al. (2012) Morbidité et mortalité du tétanos dans le service de maladies infectieuses du CHU du Point G à Bamako, Mali (2004-2009). Bulletin de la Société de pathologie exotique, 105, 58-63. https://doi.org/10.1007/s13149-011-0204-y</mixed-citation></ref><ref id="scirp.117522-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Tanon, A.K., Eholie, S.P., Coulibali, D.C., Ehui, E., Ndoumy, M., Kakou, A., et al. (2004). Mortalité et morbidité du tétanos dans un service des maladies infectieuse et tropicales d’Abidjan (1985-1998). Bulletin de la Société de pathologie exotique, 97, 283-287.</mixed-citation></ref><ref id="scirp.117522-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Aba, Y.T., Kra, O., Ehui, E., Tanon, K.A, Kacou, A.R., Ouattara, B., Bissagnéné, E. and Kadio, A. (2010) Aspects cliniques et évolutifs du tétanos lié aux soins dans le service de référence du CHU d’Abidjan. Bulletin de la Société de pathologie exotique, 104, 38-41. https://doi.org/10.1007/s13149-010-0092-6</mixed-citation></ref><ref id="scirp.117522-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Dia, N.M., Seydi, M., Manga, N.M., et al. (2009) Tétanos post-opératoire à Dakar. Rev CAMES, 8, 68-72.</mixed-citation></ref><ref id="scirp.117522-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Miguil, M., Barrou, L., Abassi, O., Idali, B. and Benaguida, M. (1995) Tétanos postopératoire: à propos de 4 cas à Casablanca (Maroc). Médecine d'Afrique noire, 42, 505-507.</mixed-citation></ref><ref id="scirp.117522-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Traoré, F.A., Youla, A.S., Sako, F.B., Sow, M.S., Keita, M., Kpamy, D.O. and Traoré, M. (2013) Le tétanos nosocomial dans le service de référence de l’h&amp;#244;pital National Donka à Conakry (2001-2011). Bulletin de la Société de pathologie exotique, 106, 104-107. https://doi.org/10.1007/s13149-013-0279-8</mixed-citation></ref><ref id="scirp.117522-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Aba, Y.T., Kra, O., Tanon, A.C., et al. (2012) Tétanos à porte d’entrée chirurgicale à Abidjan Cote d’Ivoire. Médecine et Santé Tropicales, 22, 279-282. https://doi.org/10.1684/mst.2012.0079</mixed-citation></ref><ref id="scirp.117522-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Fortes Deguenonvo, L., Leye, M.M.M., Dia, N.M., Ndiaye, R. and Lakhe, N.A. (2015) Complication of Tetanus: Report of 402 Cases at the Fann University Hospital Center of Dakar in Senegal. Journal of Tropical Diseases, 4, 182.</mixed-citation></ref><ref id="scirp.117522-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ngaha, L.A. (2014) Etude des portes d’entrée du tétanos dans le service des maladies infectieuses du centre hospitalier universitaire Yalgado Ouedraogo (Burkina Faso). Thèse de Med. Burkina Faso, No. 183.</mixed-citation></ref><ref id="scirp.117522-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Wateba, M.I., Diop, S.A., Nichola, S., Patassi, A., et al. (2008) Intérêt de la thérapie intrathécale de 1500 UI de sérum antitétanique combinée à 1, 5 gramme de métronidazole en intraveineuse sur le pronostic du tétanos en milieu hospitalier togolais. Cahiers Santé, 18, 125-129. https://doi.org/10.1684/san.2008.0115</mixed-citation></ref><ref id="scirp.117522-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Doutchi, M., Adamou, H., Magagi, I.A., Magagi, A., et al. (2017) Tétanos du postpartum sur déchirure vaginale à propos d’un cas à l’H&amp;#244;pital National de Zinder, Niger. European Scientific Journal, 13, 1857-1881. https://doi.org/10.19044/esj.2017.v13n12p301</mixed-citation></ref><ref id="scirp.117522-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Takongmo, S., Ze Minkandé. J., Jeméa, B., Guifo, M.L., Pisoh Tangnyin, C. and Simeu, C.H. (2009) Tétanos de l’adulte et chirurgie. A propos de deux cas. Health Sciences and Disease, 10, No. 4.</mixed-citation></ref><ref id="scirp.117522-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Dao, S., Oumar, A.A., Maiga, A.I., Diarra, M. and Bougoudogo, F. (2009) Tétanos en milieu hospitalier à Bamako, Mali. Médecine Tropicale, 69, 485-487.</mixed-citation></ref><ref id="scirp.117522-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Attinsounou, C.A., Seydi, M., Cissoko, Y., Déguénonvo, L.F., Nyafouna SA, D., et al. (2012) Tétanos de l’enfant et de l’adulte au Sénégal: Itinéraire thérapeutique, aspects épidémiologiques, cliniques et évolutifs. Rev.cames-série A, 13, 34-37.</mixed-citation></ref><ref id="scirp.117522-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Mier, L., Dreyfuss, D., Darchy, B., et al. (1993) Is Penicillin G an Adequate Initial Treatment for Aspiration Pneumonia? A Prospective Evaluation Using a Protected Specimen Brush and Quantitative. Intensive Care Medicine, 19, 279-284. https://doi.org/10.1007/BF01690548</mixed-citation></ref><ref id="scirp.117522-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">An, V.T., Khue, P.M., Yen, M.L., Phong, N.D. and Strobel, M. (2015) Le tétanos à H&amp;#244;-Chi-Minh-Ville, Vietnam: épidémiologie, clinique et pronostic, à propos de 389 cas à l’H&amp;#244;pital des maladies tropicales. Bulletin de la Société de pathologie exotique, 108, 342-348. https://doi.org/10.1007/s13149-015-0450-5</mixed-citation></ref><ref id="scirp.117522-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Manga, N.M., Faye, A., Ndour, C.T., et al. (2009) Facteurs pronostiques actuels du tétanos à la Clinique des Maladies Infectieuses du CHNU de Fann, Dakar. Rev CAMES-Série A, 9, 24-31.</mixed-citation></ref></ref-list></back></article>